Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-0.84	31.58	31.85
Graham Fair Price	3.03	18.04	17.51
PEG	662.83	10.23	1.34
Price/Book	16.53	2.49	2.14
Price/Cash Flow	68.37	39.32	23.36
Prices/Earnings	18.16	12.04	10.19
Price/Sales	10.27	12.05	10.93
Price/FCF	68.37	39.32	23.36
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	2.38	0.80	0.78
Operating Margin	8.87	0.48	0.44
ROA	4.20	0.02	0.02
ROE	0.05	0.05	-1.38
ROIC	0.03	0.04	20.23
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	0.01	-16.57
Dividends QOQ	-0.02	0.10	487.18
EBIT QOQ	0.13	0.18	39.94
EPS QOQ	0.08	0.01	-84.51
FCF QOQ	0.07	-0.29	304.90
Revenue QOQ	-0.02	0.08	336.14
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	0.00	inf
Days Sales Outstanding (DSO)	38.30	39.33	2.69
Inventory Turnover	44422000.00	0.00	inf
Debt/Capitalization	0.49	0.48	-1.36
Quick Ratio	0.77	0.84	8.62
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	16.12	16.73	3.75
Cash	1.89	1.24	-34.37
Capex	-0.01	< 0.005	36.29
Free Cash Flow	1.47	1.06	-28.19
Revenue	3.15	3.45	9.64
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.79	0.87	10.06
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.93	8.00	-10.40
Naive Interpretation	Member

06 - Financial Health · Bad

Rating